Swaziland turns to anti-retrovirals as safe sex message falls flat

Less than a decade ago, people were warning that Swaziland – a country of about 1.3 million – could be wiped off the map, as HIV cut life expectancy to only 45.9 in 2005.

“Every weekend was a funeral,” says health activist Bekhie Sithole.

“My parents died because of Aids-related illnesses – although it was never really stated or proven,” he says, before delivering a training session on HIV risks in the town of Ezulwini, in western Swaziland.

But a push for prevention, tests and, since 2003, anti-retroviral treatment (ART) has slowed the spread of the virus and raised life expectancy to 49, although Swaziland still has the world’s highest HIV rate, with nearly a third of adults infected.

“Things have really improved. Where you used to see people thinning and dying before us – look. You rarely meet a thin person on the street,” says Sithole.

Widespread testing of pregnant women has led to about 90% of positive mothers being put on treatment to prevent transmission to their unborn babies.

“Ninety-eight or 99% of the women are being tested when they’re pregnant and from there they are easily linked to care,” says Nduduzo Dube, a doctor at the Aids Healthcare Foundation in Manzini, Swaziland’s second city.

ART was first given to people whose viral load was high. But Dube hopes a “test and treat” regime that involves giving anyone who tests positive ARTs for life, regardless of their viral load, will help to end the epidemic.

“This is treatment as prevention … Anyone whose viral load is suppressed, transmission drops by 96%,” he says.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below